Viewing StudyNCT05918913



Ignite Creation Date: 2024-05-06 @ 7:10 PM
Last Modification Date: 2024-10-26 @ 3:01 PM
Study NCT ID: NCT05918913
Status: AVAILABLE
Last Update Posted: 2024-06-24
First Post: 2023-06-15

Brief Title: Expanded Access Program for Revumenib
Sponsor: Syndax Pharmaceuticals
Organization: Syndax Pharmaceuticals

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 2023-06-15
First Submit QC Date: June 15 2023
Study First Post Date: 2023-06-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-06-21
Last Update Post Date: 2024-06-24
Last Update Post Date Type: ACTUAL